Dose-dependent activation of distinct hypertrophic pathways by serotonin in cardiac cells

Disrupted Serotonergic and Sympathoadrenal Systems in Patients with Chronic Heart Failure May Serve as New Therapeutic Targets and Novel Biomarkers to Assess Severity, Progression and Response to Treatment

(2009) Razina R. Nigmatullina et al.   CARDIOLOGY

Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload

(2009) Olivier Lairez et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Platelet derived serotonin drives the activation of rat cardiac fibroblasts by 5-HT2A receptors

(2009) Samiye Yabanoglu et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Serotonin and Angiotensin Receptors in Cardiac Fibroblasts Coregulate Adrenergic-Dependent Cardiac Hypertrophy

(2008) Fabrice Jaffré et al.   CIRCULATION RESEARCH

Molecular regulation of cardiac hypertrophy

(2008) Sean P. Barry et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Metabolic Switch and Hypertrophy of Cardiomyocytes following Treatment with Angiotensin II Are Prevented by AMP-activated Protein Kinase

(2008) Bettina Johanna Stuck et al.   JOURNAL OF BIOLOGICAL CHEMISTRY